![5-[(6-Chloro-3-pyridazinyl)methyl]-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine](https://static.cymitquimica.com/cas-image/256626-5-6-chloro-3-pyridazinyl-methyl-2-2-fluorophenyl-5h-imidazo-45-c-pyridine.png)
CAS: 1000787-76-7 - 5-[(6-Chloro-3-pyridazinyl)methyl]-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine
Formule :C17H11ClFN5
InChI :InChI=1S/C17H11ClFN5/c18-16-6-5-11(22-23-16)9-24-8-7-14-15(10-24)21-17(20-14)12-3-1-2-4-13(12)19/h1-8,10H,9H2
Code InChI :InChIKey=JQCDICGYKWTMPP-UHFFFAOYSA-N
SMILES :FC=1C=CC=CC1C=2N=C3C=CN(C=C3N2)CC4=NN=C(Cl)C=C4
| Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
|---|---|---|---|---|
 | 5-((6-Chloropyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine REF : IN-DA008UBECAS : 1000787-76-7 | 95% | 529,00 €~624,00 € | lun 16 Déc 24 |
 | 3-chloro-6-{[2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridin-5-yl]methyl}pyridazine REF : 3D-AQB78776CAS : 1000787-76-7 | Min. 95% | À demander | lun 27 Jan 25 |
![5-((6-Chloropyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine](https://static.cymitquimica.com/products/IN/thumb/DA008UBE.jpg)
5-((6-Chloropyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine
CAS :1000787-76-7
Formule :
C17H11ClFN5
Degré de pureté :
95%
Masse moléculaire :
339.7541
Ref: IN-DA008UBE
| 1g | 624,00 € | ||
| 500mg | 529,00 € |
Livraison estimée en/au États-Unis, le lundi 16 décembre 2024
![3-chloro-6-{[2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridin-5-yl]methyl}pyridazine](https://static.cymitquimica.com/products/3D/thumb/AQB78776.jpg)
3-chloro-6-{[2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridin-5-yl]methyl}pyridazine
CAS :1000787-76-7
3-chloro-6-[2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridin-5-ylmethyl]pyridazine is an inhibitor of receptor tyrosine kinases. It inhibits the activity of tyrosine kinase …
Formule :
C17H11ClFN5
Degré de pureté :
Min. 95%
Masse moléculaire :
339.76 g/mol
Ref: 3D-AQB78776
| 1g | À demander | ||
| 500mg | À demander |
Livraison estimée en/au États-Unis, le lundi 27 janvier 2025
